In this article
Key takeaways
- UK private residential rehab typically costs £10,000-£30,000+ per month, with 28-day programmes ranging from £15,000-£20,000 at mid-market facilities.
- Sri Lankan rehab programmes offer comparable clinical quality at two to three times lower cost than equivalent UK facilities.
- UK rehab pricing is driven by property costs, UK market wages for qualified staff, CQC regulatory compliance, and substantial insurance expenses.
- Travel from London to Colombo costs approximately £500-£900 return, making total travel expenses £1,000-£2,500 - a minor factor in overall cost comparison.
- Length of stay is one of the clearest predictors of positive treatment outcomes; the cost savings in Sri Lanka can extend programme duration significantly.
What UK private rehab actually costs
The UK private residential rehabilitation market is well-established, and its pricing reflects the cost of operating in Britain. A standard 28-day programme at a reputable UK residential facility typically costs between £10,000 and £20,000. Premium facilities - particularly those in the Home Counties or with hotel-standard accommodation - regularly charge £25,000 to £30,000 or more for the same period.
These figures are not inclusive of all costs. Medical assessments, psychiatric reports, and specific clinical add-ons (EMDR therapy, specialist trauma work, certain medication protocols) are often charged separately. Post-discharge aftercare programmes, where recommended, add further cost. The total spend for a meaningful course of private residential treatment in the UK - detox included - can easily exceed £30,000 for a single month.
For a longer programme - eight weeks or twelve weeks, which evidence supports as producing better outcomes than shorter stays - the cost scales accordingly. A twelve-week stay at a mid-range UK facility could cost £50,000 to £70,000 or more.
What drives UK prices
It is worth understanding what sits behind UK rehab pricing, because it is relevant to the quality comparison with overseas alternatives.
Is this something you're dealing with?
Free confidential advice - no pressure, no obligation.
The dominant cost driver is property. A residential facility in rural England, Wales, or Scotland requires substantial premises - large enough to house patients, provide therapy rooms, catering, and outdoor space. In the UK property market, this is expensive to own or lease and expensive to maintain. Staffing is the second major factor: qualified therapists, psychiatrists, nurses, and support staff command UK market wages. Regulatory compliance - CQC registration, inspections, reporting - adds further overhead. Insurance costs for residential medical facilities in the UK are substantial.
None of these costs are unnecessary. They are simply what residential clinical care costs in Britain. The question is whether the UK regulatory framework and geographic location are themselves therapeutic requirements, or whether comparable clinical quality is achievable in a lower-cost environment. Research on residential treatment outcomes suggests the latter.
What Sri Lanka costs
A quality residential programme in Sri Lanka - including accommodation, all meals, medical supervision, daily therapeutic programming, and aftercare planning - typically costs significantly less than an equivalent UK facility. The exact pricing varies by programme and length of stay, and the most accurate figures come from a direct conversation with the facility rather than published lists, which tend to be outdated.
What can be said generally is that a 28-day programme in Sri Lanka at a high-standard facility, with clinical supervision equivalent to the UK mid-market, is considerably more affordable - often by a factor of two to three. A twelve-week stay that would cost £60,000 in the UK may be achievable in Sri Lanka at a fraction of that sum, without meaningful compromise on clinical quality.
The cost difference arises from exactly the structural factors described above. Property in Sri Lanka is substantially cheaper. Skilled clinical staff - many of whom are Western-trained - earn local market rates. The regulatory overhead is lower. The purchasing power of sterling and the Australian dollar in Sri Lanka is significant.
The quality question
The assumption that lower cost implies lower quality is understandable but does not hold in this case. The relevant comparison is not between UK and Sri Lanka regulatory frameworks - it is between the qualifications of the clinical staff, the evidence base of the treatment modalities used, the ratio of therapist contact hours per patient, and the quality of the physical environment.
On each of these measures, the best Sri Lankan programmes compare favourably with mid-market UK facilities - and on the physical environment, frequently surpass them. The therapeutic benefit of recovering in a calm, warm, nature-proximate setting is supported by neurological research in a way that recovering in a converted English manor house is not intrinsically superior to.
A note on due diligence: The absence of CQC registration does not mean an absence of clinical governance. Ask about staff qualifications, clinical supervision structures, medical protocols, and - where relevant - how psychiatric emergencies are managed. These questions have clear answers at any well-run facility.
What travel adds to the cost
A complete cost comparison must account for travel. From London, a return flight to Colombo with Sri Lankan Airlines or British Airways costs approximately £500 to £900 in economy, depending on timing and how far in advance it is booked. Business class, which some patients prefer given the 10.5-hour flight time, adds further cost.
Travel insurance should be arranged, and it is worth confirming coverage for medical treatment abroad before departure - most comprehensive travel policies include this, though the specifics vary. The total additional cost of travel for a UK patient is likely to be in the range of £1,000 to £2,500 including flights, travel insurance, and incidentals. In the context of the overall cost comparison, this is a relatively minor factor.
What you get for the total spend
The practical arithmetic for a UK patient considering both options looks something like this. A 28-day programme in the UK at a reputable mid-market facility: £15,000 to £20,000, with limited distance from home, in a British environment. A 28-day programme in Sri Lanka at an equivalent or higher clinical standard: substantially less, plus approximately £1,500 in travel costs - and with complete physical separation from the domestic environment that clinical research consistently supports as a positive factor in treatment outcomes.
For patients who could not afford UK private treatment at all, Sri Lanka may make residential care financially accessible for the first time. For patients who could afford UK private treatment, the same budget in Sri Lanka may purchase a substantially longer programme - and length of stay is one of the clearest predictors of positive outcomes in the residential treatment literature.
The NHS option - and its limitations
The NHS does provide addiction treatment services, and it is worth acknowledging them here. Community drug and alcohol teams, residential NHS placements, and structured outpatient programmes exist and serve many people well. NHS residential placements, however, are subject to significant waiting times, strict eligibility criteria, and limited availability. For someone in acute need, or someone for whom the residential environment is a clinical necessity rather than a preference, the NHS pathway may not be a practical option on the required timescale.
Many people seeking private treatment have already engaged with NHS services and found them insufficient for their circumstances. This is not a criticism of the NHS - it is a description of the gap that private residential treatment, whether in the UK or abroad, is designed to fill.
Making the comparison fairly
The honest comparison between UK and Sri Lanka private rehab is not simply a price comparison. It is a comparison of clinical quality, environment, distance, and total cost - and on all four dimensions, the case for Sri Lanka is stronger than most people in the UK initially expect. The barrier is usually the unfamiliarity of the idea, not the practical or clinical reality. That unfamiliarity typically dissolves quickly once someone asks specific questions and gets specific answers.
Get accurate pricing information
Free confidential conversation. We can give you current programme costs and help you compare options honestly.
Sources
- National Institute on Alcohol Abuse and Alcoholism (NIAAA). Alcohol Use Disorder. US Department of Health and Human Services.
- National Institute on Drug Abuse (NIDA). The Science of Addiction. National Institutes of Health.
- Substance Abuse and Mental Health Services Administration (SAMHSA). National Helpline: Free and Confidential Treatment Referral Service. US Department of Health and Human Services.